Article info
Clinical and epidemiological research
Extended report
Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study*
- Correspondence to Dr Iain B McInnes, Glasgow Biomedical Research Centre, University of Glasgow, 120 University Place, Glasgow, G12 8QQ, UK; iain.mcinnes{at}glasgow.ac.uk
Citation
Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study*
Publication history
- Received July 31, 2012
- Revised January 14, 2013
- Accepted February 14, 2013
- First published March 12, 2013.
Online issue publication
May 13, 2021
Article Versions
- Previous version (13 May 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions